Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 9 of 9 entries
Sorted by: Best Match Show Resources per page
Prostatic cancer: aetiology and endocrinology.

Hormone research

Griffiths K, Eaton CL, Davies P.
PMID: 2693331
Horm Res. 1989;32:38-43. doi: 10.1159/000181307.

Prostate cancer is common in the male population, worldwide. Several therapies are currently available, but only greater understanding of the complex processes that govern the growth of the cancer will produce real progress in treatment.

Prostate cancer.

Nursing times

[No authors listed]
PMID: 16329268
Nurs Times. 2005 Nov 22-28;101(47):21.

No abstract available.

Treatment of prostate cancer.

Clinical pharmacy

Korman LB.
PMID: 2663330
Clin Pharm. 1989 Jun;8(6):412-24.

The epidemiology, histopathology, diagnosis and staging, and treatment of prostate cancer are reviewed. Prostate cancer, one of the most common malignancies occurring in men over age 50, will strike an estimated 103,000 men in the United States in 1989....

Can lifestyle modification lower the risk of prostate cancer?.

BJU international

Kirby R, Kirby M, Fitzpatrick JM.
PMID: 20645977
BJU Int. 2010 Jul;106(2):157-9. doi: 10.1111/j.1464-410X.2010.09420.x.

No abstract available.

Fourth International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and Treatment.

The Journal of urology

Carroll PR, Chan JM, D'Amico AV, Gelmann EP, Iversen P, Klotz L, Nelson JB, Nelson PS, Nelson WG, Oh WK, Rosen N, Rubin MA, Sandler H, Sellers WR, Smith MR, Xu J, McMann MC, Kantoff PW.
PMID: 15535434
J Urol. 2004 Nov;172(5):S3-5. doi: 10.1097/01.ju.0000142276.19511.ac.

No abstract available.

Understanding dynamic interactions in the prostate tumor microenvironment.

Urologic oncology

Lang JM.
PMID: 31300353
Urol Oncol. 2019 Aug;37(8):532-534. doi: 10.1016/j.urolonc.2019.05.014. Epub 2019 Jul 09.

Complex and dynamic are 2 words that best explain the prostate tumor microenvironment (TME). These words also exemplify the challenges inherent in developing and translating the latest therapeutic advances into clinical benefit for patients with localized and advanced prostate...

Real World Evidence: A Quantitative and Qualitative Glance at Participant Feedback from a Free-Response Survey Investigating Experiences of a Structured Exercise Intervention for Men with Prostate Cancer.

BioMed research international

Fox L, Cahill F, Burgess C, Peat N, Rudman S, Kinsella J, Cahill D, George G, Santaolalla A, Van Hemelrijck M.
PMID: 28758113
Biomed Res Int. 2017;2017:3507124. doi: 10.1155/2017/3507124. Epub 2017 Jul 03.

AIM: To explore patient experiences of a structured exercise intervention for men with prostate cancer (PCa).SAMPLE: 41 men with either localised or advanced PCa who had been referred for a structured exercise programme by their physician and then subsequently...

Introduction to "Molecular drivers of prostate cancer development, progression, and resistance to therapy".

Urologic oncology

Barbieri CE.
PMID: 30064932
Urol Oncol. 2018 Aug;36(8):367. doi: 10.1016/j.urolonc.2018.06.003. Epub 2018 Jul 29.

No abstract available.

Prostate cancer: a clinical and basic science review.

Journal of andrology

Long RJ, Roberts KP, Wilson MJ, Ercole CJ, Pryor JL.
PMID: 9089063
J Androl. 1997 Jan-Feb;18(1):15-20.

No abstract available.

Showing 1 to 9 of 9 entries